Russell Investments Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Sell |
47,966
-48,758
| -50% | -$397K | ﹤0.01% | 2437 |
|
|
2025
Q1 | $759K | Buy |
96,724
+66,771
| +223% | +$524K | ﹤0.01% | 2150 |
|
|
2024
Q4 | $446K | Buy |
29,953
+19,543
| +188% | +$291K | ﹤0.01% | 2307 |
|
|
2024
Q3 | $159K | Buy |
10,410
+9,924
| +2,042% | +$152K | ﹤0.01% | 2561 |
|
|
2024
Q2 | $7.4K | Buy |
486
+476
| +4,760% | +$7.25K | ﹤0.01% | 3142 |
|
|
2024
Q1 | $189 | Sell |
10
-15,865
| -100% | -$300K | ﹤0.01% | 3279 |
|
|
2023
Q4 | $303K | Buy |
15,875
+45
| +0.3% | +$860 | ﹤0.01% | 2344 |
|
|
2023
Q3 | $284K | Sell |
15,830
-1,270
| -7% | -$22.8K | ﹤0.01% | 2410 |
|
|
2023
Q2 | $347K | Sell |
17,100
-11,105
| -39% | -$226K | ﹤0.01% | 2336 |
|
|
2023
Q1 | $514K | Buy |
28,205
+23,905
| +556% | +$436K | ﹤0.01% | 2250 |
|
|
2022
Q4 | $88.9K | Buy |
+4,300
| New | +$88.9K | ﹤0.01% | 2687 |
|
|
2021
Q3 | – | Sell |
-10,540
| Closed | -$287K | – | 3179 |
|
|
2021
Q2 | $287K | Sell |
10,540
-658
| -6% | -$17.9K | ﹤0.01% | 2795 |
|
|
2021
Q1 | $314K | Buy |
+11,198
| New | +$314K | ﹤0.01% | 2698 |
|
|
2020
Q3 | – | Sell |
-8,100
| Closed | -$200K | – | 3241 |
|
|
2020
Q2 | $200K | Buy |
+8,100
| New | +$200K | ﹤0.01% | 2711 |
|
|
2020
Q1 | – | Sell |
-20,600
| Closed | -$207K | – | 3120 |
|
|
2019
Q4 | $207K | Sell |
20,600
-715
| -3% | -$7.19K | ﹤0.01% | 2703 |
|
|
2019
Q3 | $195K | Buy |
21,315
+5,278
| +33% | +$48.3K | ﹤0.01% | 2618 |
|
|
2019
Q2 | $128K | Buy |
+16,037
| New | +$128K | ﹤0.01% | 2604 |
|